I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immune-related adverse events of anti-PD-1 immune checkpoin..:
Enikő Sebestyén
;
Nóra Major
;
Levente Bodoki
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1252215/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1252215
RT Journal T1
Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:9e98851974bb4c74bee94f1d85d3ec68&Exemplar=1&LAN=DE A1 Enikő Sebestyén A1 Nóra Major A1 Levente Bodoki A1 Attila Makai A1 Ingrid Balogh A1 Gábor Tóth A1 Zsuzsanna Orosz A1 Péter Árkosy A1 Attila Vaskó A1 Katalin Hodosi A1 Zoltán Szekanecz A1 Éva Szekanecz PB Frontiers Media S.A. YR 2023 K1 immune-checkpoint inhibitors K1 immune-related adverse events K1 anti-PD-1 K1 nivolumab K1 pembrolizumab K1 Central-Eastern Europe K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1252215/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1252215 DO https://doi.org/10.3389/fonc.2023.1252215 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)